The microfluidic tool has been tested with Ebola. It requires no bulky equipment, and is thus ideally suited for use in remote regions.
Credit
Alban Kakulya
Usage Restrictions
None
License
Licensed content
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.